AJP - Lung Cellular and Molecular Physiology, Vol 264, Issue 1 27-L35, Copyright © 1993 by American Physiological Society

ARTICLES

Trafficking of surfactant protein A in fetal rabbit lung in organ culture

J. L. Alcorn and C. R. Mendelson
Department of Biochemistry, Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas 75235.

Surfactant protein A (SP-A), a major protein component of pulmonary surfactant, is a developmentally and hormonally regulated sialoglycoprotein expressed in type II pneumonocytes. Surfactant proteins and glycerophospholipids are transported to multilamellar structures termed lamellar bodies, which serve to store surfactant lipoprotein until secretion by exocytosis into the alveolar lumen. The cellular mechanism(s) for targeting of SP-A and other surfactant components to lamellar bodies is unknown. In the present study, we have investigated the transport of SP-A to lamellar bodies in fetal rabbit lung tissue in organ culture using pulse-chase analysis of [35S]-methionine-labeled SP-A protein. SP-A accumulated in lamellar bodies within 1-3 h of synthesis; lamellar body SP-A was found to be endoglycosidase H resistant and represented 30-40% of the radiolabeled SP-A recovered from the tissue for periods of up to 12 h postlabeling. Based on our estimates of lamellar body recovery from tissue homogenates, lamellar body-associated SP-A may account for 60-80% of the SP-A present in the fetal lung explants. Treatment of fetal rabbit lung explants with inhibitors of oligosaccharide addition (tunicamycin) and processing (castanospermine), which act within the endoplasmic reticulum, significantly reduced the rate of transport of newly synthesized SP-A to lamellar bodies. An inhibitor of oligosaccharide processing that acts on a processing step that takes place within the Golgi apparatus (swainsonine) reduced the rate of transport of radiolabeled SP-A to lamellar bodies by approximately 50%.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				S. S. Phokela, S. Peleg, F. R. Moya, and J. L. Alcorn Regulation of human pulmonary surfactant protein gene expression by 1{alpha},25-dihydroxyvitamin D3 Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L617 - L626. [Abstract] [Full Text] [PDF]

				J. L. Alcorn, K. N. Islam, P. P. Young, and C. R. Mendelson Glucocorticoid inhibition of SP-A gene expression in lung type II cells is mediated via the TTF-1-binding element Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L767 - L776. [Abstract] [Full Text] [PDF]

				M. Ochs, G. Johnen, K.-M. Muller, T. Wahlers, S. Hawgood, J. Richter, and F. Brasch Intracellular and Intraalveolar Localization of Surfactant Protein A (SP-A) in the Parenchymal Region of the Human Lung Am. J. Respir. Cell Mol. Biol., January 1, 2002; 26(1): 91 - 98. [Abstract] [Full Text] [PDF]

				M. Oulton, E. Edwards, and K. Handa Convertase activity in alveolar surfactant and lamellar bodies in fetal, newborn, and adult rabbits J Appl Physiol, January 1, 1999; 86(1): 71 - 77. [Abstract] [Full Text] [PDF]

				K. Osanai, R. J. Mason, and D. R. Voelker Trafficking of Newly Synthesized Surfactant Protein A in Isolated Rat Alveolar Type II Cells Am. J. Respir. Cell Mol. Biol., December 1, 1998; 19(6): 929 - 935. [Abstract] [Full Text]